Methylprednisolone inhibits activated CD4+ T cell survival promoted by toll-like receptor ligands

Hepatobiliary and Pancreatic Diseases International

Volumn 9, Issue 4, 2010, Pages 376-383

  Lu, You Sheng ^a   Pu, Li Yong ^a   Li, Xiang Cheng ^a   Wang, Xue Hao ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

CD4+ T lymphocytes; Methylprednisolone; NF B; Toll like receptor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; METHYLPREDNISOLONE; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CPG ISLAND; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; LIGANDS; MALE; METHYLPREDNISOLONE; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; NF-KAPPA B; POLY I-C; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTOR AP-1;

EID: 77955642221     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kotsch K, Ulrich F, Reutzel-Selke A, Pascher A, Faber W, Warnick P, et al. Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial. Ann Surg 2008;248:1042-1050.
2. D'Acquisto F, Paschalidis N, Raza K, Buckley CD, Flower RJ, Perretti M. Glucocorticoid treatment inhibits annexin-1 expression in rheumatoid arthritis CD4+ T cells. Rheumatology (Oxford) 2008;47:636-639.
3. Essakalli M, Atouf O, Bennani N, Benseffaj N, Ouadghiri S, Brick C. Toll-like receptors. Pathol Biol (Paris) 2009;57:430-438.
4. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010;11:373-384.
5. Atkinson TJ. Toll-like receptors, transduction-effector pathways, and disease diversity: evidence of an immunobiological paradigm explaining all human illness? Int Rev Immunol 2008; 27:255-281.
6. Pu LY, Wang XH, Zhang F, Li XC, Yao AH, Yu Y, et al. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation. Surgery 2007;142:67-73.
7. Oviedo-Orta E, Perreau M, Evans WH, Potolicchio I. Control of the proliferation of activated CD4+ T cells by connexins. J Leukoc Biol 2010;88:79-86.
8. Mäkelä SM, Strengell M, Pietilä TE, Osterlund P, Julkunen I. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells. J Leukoc Biol 2009;85:664-672.
9. Sang Y, Yang J, Ross CR, Rowland RR, Blecha F. Molecular identification and functional expression of porcine Toll-like receptor (TLR) 3 and TLR7. Vet Immunol Immunopathol 2008;125:162-167.
10. Han KY, Kwon TH, Lee TH, Lee SJ, Kim SH, Kim J. Suppressive effects of Lithospermum erythrorhizon extracts on lipopolysaccharide-induced activation of AP-1 and NFkappaB via mitogen-activated protein kinase pathways in mouse macrophage cells. BMB Rep 2008;41:328-333.
11. Valera FC, Queiroz R, Scrideli C, Tone LG, Anselmo-Lima WT. Expression of transcription factors NF-kappaB and AP-1 in nasal polyposis. Clin Exp Allergy 2008;38:579-585.
12. Kondadasula SV, Varker KA, Lesinski GB, Benson DM Jr, Lehman A, Olencki T, et al. Activation of extracellular signaling regulated kinase in natural killer cells and monocytes following IL-2 stimulation in vitro and in patients undergoing IL-2 immunotherapy: analysis via dual parameter flow-cytometric assay. Cancer Immunol Immunother 2008;57:1137-1149.
13. Lv XH, Zhou LP, Liu DP, Wang Y, Wang BY, Fu BY, et al. Traditional Chinese medicine Kang Xian Fu Fang I is effective for prophylaxis and treatment of alcoholic liver disease in rats. Hepatobiliary Pancreat Dis Int 2007;6:182-187.
14. Grillot DA, Merino R, Pena JC, Fanslow WC, Finkelman FD, Thompson CB, et al. bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. J Exp Med 1996;183:381-391.
15. Akira S, Yamamoto M, Takeda K. Role of adapters in Toll-like receptor signalling. Biochem Soc Trans 2003;31:637-642.
16. Takeuchi O, Akira S. MyD88 as a bottle neck in Toll/IL-1 signaling. Curr Top Microbiol Immunol 2002;270:155-167.
17. May MJ, D'Acquisto F, Madge LA, Glöckner J, Pober JS, Ghosh S. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 2000;289:1550-554.
18. Lee SS, Tsai CH, Yang SF, Ho YC, Chang YC. Hypoxia inducible factor-1alpha expression in areca quid chewing-associated oral squamous cell carcinomas. Oral Dis 2010 May 30;[Epub ahead of print].
19. Zarember KA, Godowski PJ. Tissue expression of human Tolllike receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002;168:554-561.
20. Applequist SE, Wallin RP, Ljunggren HG. Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines. Int Immunol 2002;14:1065-1074.
21. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdörfer B, Giese T, Endres S, Hartmann G. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002;168:4531-4537.
22. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003;197:403-411.
23. Rozkova D, Horvath R, Bartunkova J, Spisek R. Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors. Clin Immunol 2006;120:260-271.
24. Tong HS, Zhang Y, Yuan K, Fu XW. HBsAg loading on dendritic cells in patients with chronic hepatitis B: expressions of phenotypic molecules. Hepatobiliary Pancreat Dis Int 2006; 5:56-59.
25. Zhang H, Zheng SS, Jiang GP, Wu LH, Zhu F, Yang ZL. Antitumor effect of immunization with fusion of dendritic cells and hepatocellular carcinoma cells in mice. Hepatobiliary Pancreat Dis Int 2004;3:235-240.